Background: Quality-switched (QS) laser therapy is a safe and well-established treatment option for removing solar lentigines. Triple combination therapy (TCT) with the active pharmaceutical ingredients hydroquinone 5%, tretinoin 0.03%, and dexamethasone 0.03% is often used for skin-lightening.

Objective: This prospective, open-label trial compares the efficacy and safety of a QS Ruby laser (QSRL) and a TCT in the treatment of solar lentigines.

Methods: In total, 15 patients with symmetrically distributed solar lentigines on the back of both hands were included. The lesions on the back of the right hand were treated in one or 2 sessions with a QSRL, the ones on the back of the left hand with a TCT for 7 weeks accompanied by UV protection. Clinical results were evaluated 4 weeks, 8 weeks, and 20 weeks after baseline.

Results: Treatment with QSRL provided significant lightening (p = .01) compared with TCT. Both procedures were generally well-tolerated. Comparing the side effects, the laser produced significantly more crusting and hyperpigmentation than the TCT.

Conclusion: Both QSRL and TCT were capable in reducing solar lentigines in Fitzpatrick skin Type I to IV with an acceptable side effect profile. The QSRL provides faster, superior, and long lasting lightening compared with TCT.

Download full-text PDF

Source
http://dx.doi.org/10.1097/DSS.0000000000000793DOI Listing

Publication Analysis

Top Keywords

solar lentigines
16
ruby laser
8
triple combination
8
treatment solar
8
qsrl tct
8
weeks weeks
8
lightening compared
8
compared tct
8
tct
6
solar
5

Similar Publications

Background: Skin pigmentation disorders may increase patients' psychological burdens. Consequently, they are increasingly attracting attention. Dermal fibroblasts have been shown to regulate pigmentation by secreting soluble factors.

View Article and Find Full Text PDF

Little is known about the anti-pigmenting effects of skin-whitening agents on solar lentigos (SLs). To characterize the anti-pigmenting effects of a newly designed derivative ascorbyl glucoside-arginine complex (AGAC) on SLs, lotions with or without 28% AGAC were applied twice daily for 24 weeks in a double-blind half-face study of 27 Japanese females with SLs. The pigmentation scores and skin colors of previously selected SLs on the right and left sides of the faces of the subjects were evaluated using a photo-scale, a color difference meter and a Mexameter.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the link between Parkinson's disease (PD) and skin cancer risk factors, looking specifically at actinic keratosis (AK), non-melanoma skin cancer (NMSC), and cutaneous malignant melanoma (CMM) among individuals with and without PD.
  • A total of 141 patients with PD and 155 controls were analyzed, revealing that CMM was more prevalent in PD patients, with risk factors like prolonged sun exposure, freckles, and solar lentigines particularly associated with skin tumours in the PD group.
  • The research indicates that while certain skin tumour risk factors exist, PD status by itself isn't independently linked to these risks, highlighting the need for regular dermatological
View Article and Find Full Text PDF

The Skin-Lightening Power of Tirbanibulin 1% Ointment.

Dermatol Ther (Heidelb)

November 2024

Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, Messina, Italy.

Background: Tirbanibulin 1% ointment has been licensed to treat non-hyperkeratotic actinic keratosis (AK) on the face and scalp in adults. Recent evidence suggests that, besides the antineoplastic effect, tirbanibulin may also confer substantial cosmetic benefits to patients.

Methods: We report a single-center retrospective study of patients affected by solar lentigines (SLs) and AKs in the context of field cancerization treated with tirbanibulin 1% ointment.

View Article and Find Full Text PDF
Article Synopsis
  • Facial pigmented skin lesions are common, especially in South-European countries, and can be either malignant or benign; diagnosing them can be challenging, even for specialists like dermatologists.* -
  • A study was conducted to assess the impact of a one-day dermoscopy training course on ophthalmologists, focusing on their ability to evaluate periorbital pigmented lesions through clinical and dermoscopic analysis.* -
  • Results showed that before the training, ophthalmologists had an accuracy of 63.7%, but after the course, their sensitivity improved, indicating a positive effect of the training on their diagnostic skills.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!